SB 1553: Authorizes incentives for producing certain critical materials and pharmaceuticals
SB 1553 status: Enacted — Signed by Governor (updated Jul 13, 2026).
What this bill does
Overall score
Bill summary
OfficialSS/SB 1553 - This act modifies provisions relating to incentives for producing certain critical materials and pharmaceuticals. MANUFACTURING SALES TAX EXEMPTION Current law authorizes a sales tax exemption for energy, machinery, equipment, and materials used or consumed in the manufacturing, processing, compounding, mi...
Key analysis
Impact analysis
Environment
Benefits
- no direct environmental policy changes identified
Risks
- no direct environmental policy changes identified
Economy
Benefits
- incentivizes domestic capital investment
- supports supply chain resilience
Risks
- creates ongoing fiscal liability of up to $40M annually
- potential for inefficient capital allocation
Society
Benefits
- increases accessibility/availability of critical pharmaceuticals
- encourages local job creation in strategic sectors
Risks
- reliance on corporate tax incentives may divert funds from other social services
How trustworthy & consequential it is
LegiScan returned a PDF-only document. PDF extraction is not enabled in this build, so the pipeline used a safer fallback.
Analysis based on summary; specific definitions of critical materials and pharmaceuticals are not provided
Where it stands
Introduced
CompleteCommittee
CompleteFloor
CompleteGovernor
CompleteEnacted
CompleteHow it affects your district
Set your location
Add your district to see how this bill may affect your community and who to contact.
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.